The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 20,501–20,600 of 31,469
Hitsumoto, T. (2017) · Cardiology Research · doi:10.14740/cr545w · Cited by 10
Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?
Kızılgül, M., Kan, S., Beysel, S., Apaydın, M., Özçelik, Ö., Çalışkan, M., Özbek, M., Özdemir, Ş., & Çakal, E. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000287 · Cited by 11
de Groot, M., Marrero, D. G., Mele, L., Doyle, T. A., Schwartz, F., Mather, K. J., Goldberg, R. B., Price, D. W., Ma, Y., & Knowler, W. C. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000535 · Cited by 10
A non-linear data mining parameter selection algorithm for continuous variables
Tavallali, P., Razavi, M., & Brady, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187676 · Cited by 10
Kęska, A., Lutosławska, G., Mazurek, K., Czajkowska, A., Tkaczyk, J., & Iwańska, D. (2017) · American Journal of Men s Health · doi:10.1177/1557988317743151 · Cited by 10
Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model
Watanabe, K., Ohta, M., Takayama, H., Tada, K., Shitomi, Y., Kawasaki, T., Kawano, Y., Endo, Y., Iwashita, Y., & Inomata, M. (2017) · Obesity Surgery · doi:10.1007/s11695-017-3052-4 · Cited by 10
Lithgow, H., & Leggate, M. (2018) · International journal of exercise science · doi:10.70252/wfkf5811 · Cited by 10
Influence of physical inactivity on arterial compliance during a glucose challenge
Credeur, D. P., Reynolds, L. J., Holwerda, S. W., Vranish, J. R., Young, B. E., Wang, J., Thyfault, J. P., & Fadel, P. J. (2018) · Experimental Physiology · doi:10.1113/ep086713 · Cited by 10
McGrath, T., Murphy, K. G., & Jones, N. S. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0736 · Cited by 10
Maruo, S., Mori, K., Motoyama, K., Nakamura, M., Kawarabayashi, R., Kakutani, Y., Yamazaki, Y., Morioka, T., Shoji, T., Inaba, M., et al. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0187-4 · Cited by 10
Wang, Y., Zhou, W., Wu, C., Zhang, Y., Lin, T.-C., Sun, Y. W., Liu, W. X., & Tao, T. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0331-4 · Cited by 10
Circulating Irisin Levels in Children With GH Deficiency Before and After 1 Year of GH Treatment
Ciresi, A., Pizzolanti, G., Guarnotta, V., & Giordano, C. S. D. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01440 · Cited by 10
Nelder, M., Cahill, F., Zhang, H., Zhai, G., Gulliver, W. P., Teng, W., Shan, Z., & Sun, G. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00661 · Cited by 12
Aulie, H. A., Estensen, M. E., Selvaag, A. M., et al. (2018) · Pediatric Rheumatology · doi:10.1186/s12969-018-0302-5 · Cited by 10
Doğan, T., Öztürk, K., Çelikkanat, S., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001431 · Cited by 10
Cardiometabolic importance of 1-h plasma glucose in obese subjects
Haverals, L., Dessel, K. V., Verrijken, A., et al. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0084-y · Cited by 10
de Luis, D. A., Izaola, O., Primo, D., & Aller, R. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107825 · Cited by 10
Boughanem, H., Bandera-Merchán, B., Hernández‐Alonso, P., Moreno-Morales, N., Tinahones, F. J., Lozano, J., Morcillo, S., & Macías‐González, M. (2020) · Biomedicines · doi:10.3390/biomedicines8030044 · Cited by 11
Chakraborty, S., Prasad, G., Marwaha, R. K., Basu, A., Tandon, N., & Bharadwaj, D. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1631_18 · Cited by 10
Stenberg, E., Rask, E., Szabó, É., Näslund, I., & Ottosson, J. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04599-w · Cited by 11
Taltavull, N., Miralles‐Pérez, B., Nogués, M. R., Ramos‐Romero, S., Méndez, L., Medina, I., Torres, J. L., & Romeu, M. (2020) · Marine Drugs · doi:10.3390/md18060318 · Cited by 10
Jaleel, G. A. A., Awdan, S. A. E., Ahmed, R. F., Ahmed-Farid, O. A.-H., & Saleh, D. O. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00593-4 · Cited by 10
Dichtel, L. E., Kimball, A., Yuen, K. C. J., Woodmansee, W. W., Haines, M. S., Guan, Q. X., Swearingen, B., Nachtigall, L. B., Tritos, N. A., Sharpless, J. L., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14309 · Cited by 10
Marzullo, P., Mele, C., Minocci, A., Mai, S., Scacchi, M., Sartório, A., Aimaretti, G., & Grugni, G. (2020) · Nutrients · doi:10.3390/nu12092583 · Cited by 10
Parente, D. B., Perazzo, H., Paiva, F. F., Campos, C. F. F., Saboya, C. J., Pereira, S., Silva, F. D. E., Rodrigues, R. S., & Perez, R. D. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-71723-2 · Cited by 10
Atıcı, A., Asoğlu, R., Barman, H. A., Sarıkaya, R., Arman, Y., & Tükek, T. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-02037-7 · Cited by 10
Aakre, K. M., Omland, T., Nordstrand, N., Gjevestad, E. S., Holven, K. B., Lyngbakken, M. N., & Hjelmesaeth, J. S. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.09.006 · Cited by 10
Halama, A., Suleiman, N., Kuliński, M., Bettahi, I., Hassoun, S., Alkasem, M., Abdalhakam, I., Iskandarani, A., Samra, T. A., Atkin, S. L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73723-8 · Cited by 10
Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome
Vatannejad, A., Salimi, F., Moradi, N., Fouani, F. Z., Zandieh, Z., Ansaripour, S., Sadeghi, A., & Fadaei, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118595 · Cited by 11
Lee, C.-L., Liu, W.-J., & Wang, J. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.019 · Cited by 11
Subias-Gusils, A., Boqué, N., Caimari, A., Bas-Prior, J. M. D., Mariné-Casadó, R., Solanas, M., & Escorihuela, R. M. (2021) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1870037 · Cited by 10
Fat mass and vascular health in overweight/obese children
Licenziati, M. R., Iannuzzo, G., Morlino, D., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.017 · Cited by 10
Vázquez‐Moreno, M. A., Locia‐Morales, D., Valladares‐Salgado, A., Sharma, T., Pérez‐Herrera, A., González‐Dzib, R., Rodríguez-Ruíz, F., Wacher, N. H., Cruz, M., & Meyre, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-82728-w · Cited by 10
IGFBP-1 and IGFBP-2 are associated with a decreased pulse-wave velocity in young, healthy adults
Pettersson-Pablo, P., Nilsson, T., Breimer, L. H., et al. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01914-w · Cited by 10
Leptin and the GA genotype of rs2167270 of the LEP gene increase the risk of prediabetes
Aljanabi, M., Alfaqih, M. A., Khanfar, M., Amarin, Z. O., Elsalem, L., Saadeh, R., & Al‐Μughales, F. (2021) · Biomedical Reports · doi:10.3892/br.2021.1420 · Cited by 12
Yuen, F., Thirumalai, A., Fernando, F., Swerdloff, R. S., Liu, P. Y., Pak, Y., Hull, L., Bross, R., Blithe, D., Long, J. E., et al. (2021) · Andrology · doi:10.1111/andr.13025 · Cited by 10
β-Cell Function and Clinical Outcome in Nondiabetic Patients With Acute Ischemic Stroke
Kiyohara, T., Matsuo, R., Hata, J., Nakamura, K., Wakisaka, Y., Kamouchi, M., Kitazono, T., Ago, T., Ishitsuka, T., Ibayashi, S., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.031392 · Cited by 10
Chamorro, R., Wilms, B., Holst, A., Röhl, C., Mölle, M., Knaak, A., Meyhöfer, S., Lehnert, H., & Schmid, S. M. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.05.038 · Cited by 10
Serum neudesin levels in patients with polycystic ovary syndrome
Yilmaz, H., Demirpençe, M., Çolak, A., Akşit, M. Z., Yaşar, E., & Taylan, A. (2021) · Ginekologia Polska · doi:10.5603/gp.a2021.0139 · Cited by 10
Derosa, G., D’Angelo, A., & Maffioli, P. (2021) · Life · doi:10.3390/life11070709 · Cited by 10
Yuan, X., Ding, S., Zhou, L., Wen, S., Du, A., & Diao, J. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1671 · Cited by 11
Ye, X., Zhang, J., Jin, Y.-J., Shen, D., Hao, X., Li, J., Zhong, J., Jin, L., Tong, L., & Gao, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719462 · Cited by 10
Lower sexual satisfaction in women with polycystic ovary syndrome and metabolic syndrome
Kałużna, M., Nomejko, A., Słowińska, A. M., Wachowiak-Ochmańska, K., Pikosz, K., Ziemnicka, K., & Ruchała, M. (2021) · Endocrine Connections · doi:10.1530/ec-21-0257 · Cited by 11
Resende, B., Beleigoli, A. M. R., Ribeiro, A. L. P., et al. (2021) · Parasitology International · doi:10.1016/j.parint.2021.102440 · Cited by 10
Vivek, S., Carnethon, M. R., Prizment, A. E., Carson, A. P., Bancks, M. P., Jacobs, D. R., & Thyagarajan, B. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109004 · Cited by 10
Nadig, P. D., Asanaliyar, M., & Salis, K. M. (2021) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.2021.38 · Cited by 10
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B
Chun, H. S., Lee, J. S., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., & Kim, S. U. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07157-1 · Cited by 10
Jao, J. K., Balmert, L. C., Sun, S., McComsey, G. A., Brown, T. T., Tien, P. C., Currier, J. S., Stein, J. H., Qiu, Y., LeRoith, D., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab663 · Cited by 11
Wu, P., Wang, Y., Ye, Y., Yang, X., Lu, Q., Liu, Y., Zeng, H., Song, X., Yan, S., Wen, Y. R., et al. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3496 · Cited by 10
Evaluation the effects of insulin on oxidant/antioxidant status in type 1 diabetic patients
Almulathanon, A. A. Y., Mohammad, J. A., & Allwsh, T. A. (2021) · Pharmacia · doi:10.3897/pharmacia.68.e70495 · Cited by 10
Turdi, H., Chao, H. J., Hangeland, J. J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01356 · Cited by 10
GLP-1: 10-year follow-up after Roux-en-Y gastric bypass
de Carvalho, C. P., de Souza, A. L., Batista, G. A., Duran, L. F. T., Fernandes, D. P., Molina, V. B. C., Gonçalves, R. A., Giorgetti, J. S., Chaim, É. A., & Alegre, S. M. (2021) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02341-3 · Cited by 10
Miller, L., Thompson, K., Pavlenco, C., Mettu, V. S., Haverkamp, H. C., Skaufel, S., Basit, A., Prasad, B., & Larsen, J. (2021) · Nutrients · doi:10.3390/nu13103620 · Cited by 10
Yang, C., Liu, X., Li, J., Yan, N., Dang, Y., Chang, Z., Wang, K., Liu, X., Zhao, Y., & Zhang, Y. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0120 · Cited by 10
Corrêa, C. R., da Costa, B. G. G., da Silva, K. S., et al. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13012 · Cited by 10
Venkatesan, V., López-Alvarenga, J. C., Arya, R., Ramu, D., Koshy, T., Ravichandran, U., Ponnala, A. R., Sharma, S. K., Lodha, S., Sharma, K. K., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.847692 · Cited by 10
Tsai, P.-L., Chang, H. H., & Chen, P. S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050693 · Cited by 11
Ability of TyG Index as a Marker of Insulin Resistance in Argentinean School Children
Hirschler, V., Molinari, C., Scaiola, E., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.885242 · Cited by 10
Associations between Hair Mineral Concentrations and Skeletal Muscle Mass in Korean Adults
Lee, Y.-A., Kim, H.-N., & Song, S.-W. (2022) · The journal of nutrition health & aging · doi:10.1007/s12603-022-1789-5 · Cited by 10
Łapińska, L., Stachurska, Z., Raczkowski, A., Waszkiewicz, N., Kamiński, K. A., & Kowalska, I. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16261 · Cited by 10
Abd‐Elrazek, A., Ibrahim, S. R., & El‐dash, H. A. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00416-6 · Cited by 10
FADS Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic Syndrome
Žák, A., Jáchymová, M., Burda, M., Staňková, B., Zeman, M., Slaby, A., Vecka, M., & Šeda, O. (2022) · Metabolites · doi:10.3390/metabo12060568 · Cited by 13
Dysbiosis in Children With Neurological Impairment and Long-Term Enteral Nutrition
Panelli, S., Calcaterra, V., Verduci, E., Comandatore, F., Pelizzo, G., Borghi, E., Bandi, C., & Zuccotti, G. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.895046 · Cited by 10
Yoshiko, A., Maeda, H., Takahashi, H., Koike, T., Tanaka, N., & Akima, H. (2022) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2021-0685 · Cited by 10
Monfort‐Pires, M., Regeni-Silva, G., Dadson, P., Nogueira, G. A. S., U-Din, M., Ferreira, S. R. G., Sapienza, M. T., Virtanen, K. A., & Velloso, L. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.919588 · Cited by 10
Wingrove, J. O., O’Daly, O., Rubio, A. D. L., Hill, S., Swedroska, M., Forbes, B., Amiel, S. A., & Zelaya, F. O. (2022) · Human Brain Mapping · doi:10.1002/hbm.26019 · Cited by 9
Glucose metabolism in systemic juvenile idiopathic arthritis
Suppasit, P., Vilaiyuk, S., Poomthavorn, P., et al. (2022) · Pediatric Rheumatology · doi:10.1186/s12969-022-00714-6 · Cited by 10
Muendlein, A., Heinzle, C. F., Leiherer, A., Geiger, K. D., Brandtner, E. M., Gaenger, S., Fraunberger, P., Saely, C. H., & Drexel, H. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.08.018 · Cited by 10
The effect of obesity-related allostatic changes on cardio-metabolic risk in euthyroid children
Tropeano, A., Corica, D., Curatola, S., Pomi, A. L., Casto, C., Alibrandi, A., Pepe, G., Aversa, T., & Wasniewska, M. G. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01899-z · Cited by 10
Beunen, K., Vercauter, L., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.973820 · Cited by 10
Zhang, X., Du, L., Zhang, W., et al. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.03.034 · Cited by 10
Insulin resistance in moderate to severe acne vulgaris
Singh, M., & Shri, D. (2022) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_396_21 · Cited by 10
Tsoi, K. Y., Zhu, Y., Wu, J., Sun, Q., Hinkle, S. N., Li, L., Chen, Z., Weir, N. L., Tsai, M. Y., Ronald, C. W., et al. (2022) · Diabetes · doi:10.2337/db22-0241 · Cited by 10
Brunnert, L., Puasa, I. D., Garten, A., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1030809 · Cited by 10
The metabolic health of young men conceived using intracytoplasmic sperm injection
Catford, S. R., Halliday, J. L., Lewis, S., O’Bryan, M. K., Handelsman, D. J., Hart, R. J., McBain, J., Rombauts, L. J. F., Amor, D. J., Saffery, R., et al. (2022) · Human Reproduction · doi:10.1093/humrep/deac212 · Cited by 12
Thomas, J. V., Patel, A. A., Syam Das, S., Sreevallabhan, S., Krishnakumar, I. M., & Ratheesh, M. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105273 · Cited by 10
Juárez-Rojas, J. G., Medina-urrita, A. X., Galarza, E. J., Hafidi, M. E., Reyes-Barrera, J., Páez, A., Masso-Rojas, F. A., Martínez‐Sánchez, F. D., López-Uribe, Á. R., González-Salazar, M. D. C., et al. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.04084 · Cited by 10
Silva, F. M., Duarte‐Mendes, P., Carvalho, E., Soares, C., Farinha, C. M. N., Serrano, J., Paulo, R. M., Massart, A. G. M., Rodrigues, R. N., Teixeira, A. M., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1040714 · Cited by 11
Meshkani, M., Saedisomeolia, A., Yekaninejad, M. S., Mousavi, S. A., Ildarabadi, A., & Dastjerdi, M. V. (2022) · Clinical Nutrition Research · doi:10.7762/cnr.2022.11.4.241 · Cited by 11
Zhang, X., Yang, Q., Zheng, R., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13353 · Cited by 10
Salarinia, M., Azizi, M., Tahmasebi, W., & Khalvandi, H. (2023) · Science & Sports · doi:10.1016/j.scispo.2022.04.008 · Cited by 10
Yang, L., Zhou, J., Zheng, Y., Hu, X., He, Z., Du, L.-J., Gu, X., Huang, X., Li, Y., Li, Y. Q., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02006-6 · Cited by 10
Linn, O., Menges, B., Lammert, F., et al. (2023) · Nutrients · doi:10.3390/nu15030754 · Cited by 10
Li, Y., Jiang, Y., Zhang, S., Liu, H., & Zhang, C. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s399105 · Cited by 11
Watanabe, Y., Yamaguchi, T., Nagayama, D., Tanaka, S., Sasaki, A., Naitoh, T., Matsubara, H., Yokote, K., Okazumi, S., Ugi, S., et al. (2023) · Obesity Facts · doi:10.1159/000529546 · Cited by 11
Glycaemic status, insulin resistance, and risk of infection-related mortality: a cohort study
Cheong, H. S., Chang, Y., Kim, Y., Joo, E., Kwon, M., Wild, S. H., Byrne, C. D., & Ryu, S. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad011 · Cited by 10
Valero‐Breton, M., Valladares-Ide, D., Álvarez, C., Peñailillo, R. S., & Peñailillo, L. (2023) · Nutrients · doi:10.3390/nu15040908 · Cited by 10
Maidadi, B., Ntchapda, F., Miaffo, D., & Mahamad, A. T. (2023) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2023.03.001 · Cited by 10
Xie, Q., Jia, X., Zhang, W., Xu, Y., Zhu, M., Zhao, Z., Hao, J., Li, H., Du, J., Liu, Y., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3245 · Cited by 9
Thao, T. T. P., Mến, T. T., Đái, T. X. T., & Linh, T. C. (2023) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2023.03.007 · Cited by 11
Chen, Y., Feuerstahler, L. M., Steele, E. M., Buckley, J. P., & Liu, S. H. (2023) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-023-00535-z · Cited by 10
Ren, Z., Luo, S., & Liu, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104180 · Cited by 10
Zaitoon, H., Lubetzky, R., Amir, A. Z., Moran‐Lev, H., Sagi, L., Bach, M. Y., Borger, O., Chorna, E., Lebenthal, Y., & Brener, A. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02109-9 · Cited by 10
Eyck, A. V., Ledeganck, K. J., Vermeiren, E., et al. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05046-5 · Cited by 10
Soghomonian, A., Dutour, A., Kachenoura, N., Thuny, F., Lasbleiz, A., Ancel, P., Cristofari, R., Jouve, É., Siméoni, U., Kober, F., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1181452 · Cited by 10
Antoniotti, V., Amore, M., Caputo, M., Fania, C., Mancioppi, V., Casoli, G., Tini, S., Antonioli, A., Aimaretti, G., Rabbone, I., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad088 · Cited by 10
Mansouri, E., Asghari, S., Nikooei, P., Yaseri, M., Vasheghani‐Farahani, A., & Hosseinzadeh‐Attar, M. J. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2223390 · Cited by 10
Al‐Okbi, S. Y., Ali, O. S. M., Aly, A. S., Refaat, D., Esmail, R. S. H., & Elbakry, H. F. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-38837-9 · Cited by 10
Beta‐cell function in type 2 diabetes ( T2DM ): Can it be preserved or enhanced?
Kassem, L. S., Rajpal, A., Barreiro, M. V. E., & Ismail‐Beigi, F. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13446 · Cited by 14
Rigamonti, A. E., Dei, M., Caroli, D., Bondesan, A., Cella, S. G., Paroni, R. C., & Sartório, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512452 · Cited by 11
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
